Lyme disease: What’s actually going on here?
A ‘typical’ case of Lyme disease looks like this: a person in an area populated by the Ixodes scapularis tick gets…
Read More…
Focus:
-
![Sandoz; Aurobindo Pharma]()
Novartis terminates $1bn Sandoz US deal with Aurobindo
Novartis and Aurobindo Pharma USA have signed a mutual agreement to terminate their deal covering...
Read More...
-
![digital biomarkers]()
Digital biomarkers are emerging as important predictive tools to support the global Covid-19 pandemic
Digital biomarkers are objective, quantifiable, physiological, and behavioural measures collected remotely by digital devices, such as smartphones and wearables. These…
Read More…
-
![ImmunityBio and Microsoft Covid-19]()
ImmunityBio and Microsoft create 3D model to support Covid-19 research
Immunotherapy company ImmunityBio has partnered with Microsoft to leverage the latter’s Azure platform to create...
Read More...
-
![psoriatic arthritis]()
Significant unmet needs remain in the global psoriatic arthritis market
Despite the plethora of drugs currently available for patients with psoriatic arthritis, several key unmet needs remain. GlobalData has identified…
Read More…
-
![Coronavirus in South Korea]()
Coronavirus in South Korea: COVID-19 outbreak, measures and impact
Neighbouring two coronavirus-affected countries China and Japan, South Korea is among the top ten countries...
Read More...
-
![Coronavirus in India]()
Coronavirus in India: how the COVID-19 could impact the fast-growing economy
India reported the first confirmed case of the coronavirus infection on 30 January 2020 in...
Read More...
-
![Coronavirus outbreak - The countries affected]()
Coronavirus outbreak: The countries affected
The 2019 novel coronavirus (2019-nCoV), officially named as COVID-19 by the WHO, has spread to...
Read More...
-
![US Covid-19 cases]()
US Covid-19 cases projected to increase 65% by 5 April
In the key markets most heavily affected by Covid-19, GlobalData epidemiologists expect the case trend in the next weeks to…
Read More…
-
![Exscientia Covid-19]()
Exscientia forms UK-US partnership to screen possible Covid-19 drugs
Artificial intelligence (AI) drug discovery company Exscientia has expanded its ongoing anti-viral drugs partnership with...
Read More...
